| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Internal Medicine (W.E.V., T.J.V.), Bioinformatics (S.M.A.S., P.J.v.d.S.), and Genetics (S.M.A.S.), Center for Biomics (Z.O., W.F.J.v.I.), Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands; Department of Endocrinology and Metabolic Diseases (K.A.H., E.P.C., J.W.A.S.), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; and Center for Human Drug Research (J.B.), 2333 CL Leiden, The Netherlands
Address all correspondence and requests for reprints to: Theo J. Visser, Ph.D., Erasmus University Medical Center, Department of Internal Medicine, Room Ee 502, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail: t.j.visser{at}erasmusmc.nl.
Context: Skeletal muscle is an important target tissue for thyroid hormone (TH). It is currently unknown which genes are regulated by physiological TH levels.
Objective: We examined the effects of L-thyroxine on human skeletal muscle transcriptome.
Design: Microarray analysis of transcript levels was performed using skeletal muscle biopsies from patients under euthyroid and hypothyroid conditions.
Setting: The study was conducted in a university hospital laboratory.
Patients: We studied skeletal muscle obtained from 10 thyroidectomized patients with differentiated thyroid carcinoma on and after 4 wk off L-thyroxine replacement.
Mean Outcome Measures: Gene expression changes were measured using microarrays. Results were analyzed using dedicated statistical methods.
Results: We detected 607 differentially expressed genes on L-thyroxine treatment, of which approximately 60% were positively and approximately 40% were negatively regulated. Representative genes were validated by quantitative PCR. Genes involved in energy and fuel metabolism were overrepresented among the up-regulated genes, of which a large number were newly associated with thyroid state. L-thyroxine therapy induced a large down-regulation of the primary transcripts of the noncoding microRNA pair miR-206/miR-133b.
Conclusion: We demonstrated that physiological levels of TH regulate a myriad of genes in human skeletal muscle. The identification of novel putatively TH-responsive genes may provide the molecular basis of clinical effects in subjects with different TH status. The observation that TH regulates microRNAs reveals a new layer of complexity by which TH influences cellular processes.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |